TIANDA PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.26 HKD | 0.00% |
|
+4.00% | +19.27% |
| Sales 2021 | 474M 60.57M | Sales 2022 | 547M 69.82M | Capitalization | 871M 111M |
|---|---|---|---|---|---|
| Net income 2021 | -27M -3.45M | Net income 2022 | -54M -6.9M | EV / Sales 2021 | 1.26 x |
| Net cash position 2021 | 92.43M 11.8M | Net cash position 2022 | 224M 28.62M | EV / Sales 2022 | 1.18 x |
| P/E ratio 2021 |
-25.4
x | P/E ratio 2022 |
-15.9
x | Employees | 863 |
| Yield 2021 |
0.81% | Yield 2022 |
0.86% | Free-Float | 20.57% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +4.00% | ||
| 1 week | +4.00% | ||
| 1 month | -5.45% | ||
| 3 months | +28.71% | ||
| 6 months | +22.07% | ||
| Current year | +19.27% |
1 week
0.25
0.26
1 month
0.250.28
Current year
0.180.28
1 year
0.170.28
3 years
0.150.43
5 years
0.120.43
10 years
0.120.61
| Managers | Title | Age | Since |
|---|---|---|---|
Wen Quan Fang
CEO | Chief Executive Officer | 55 | 02-12-31 |
Tai On Lo
SEC | Corporate Secretary | 69 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sung Hong Chiu
BRD | Director/Board Member | 77 | 08-04-09 |
Yat Fai Lam
BRD | Director/Board Member | 58 | 03-12-31 |
Wen Quan Fang
CEO | Chief Executive Officer | 55 | 02-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 0.26 | 0.00% | 0 |
| 24-04-18 | 0.26 | +4.00% | 4,000 |
| 24-04-17 | 0.25 | +1.63% | 6,000 |
| 24-04-16 | 0.246 | -1.20% | 50,000 |
| 24-04-15 | 0.249 | +0.81% | 304,000 |
Delayed Quote Hong Kong S.E., April 18, 2024 at 04:08 am EDT
More quotes
Tianda Pharmaceuticals Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The main businesses of the Company include the research and development, production and sales of pharmaceutical, biotechnology and healthcare products. Its products include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. The Company operates businesses in Hong Kong, China and Australia.
Sector
Pharmaceuticals
Calendar
2024-06-25
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +19.27% | 71.38M | |
| +27.97% | 672B | |
| +23.58% | 550B | |
| -7.02% | 351B | |
| +14.85% | 317B | |
| +6.25% | 292B | |
| +2.96% | 211B | |
| -0.41% | 203B | |
| -10.02% | 194B | |
| -11.81% | 144B |
- Stock Market
- Equities
- 455 Stock
